Quince Therapeutics announces fast track designation for EryDex System
PremiumThe FlyQuince Therapeutics announces fast track designation for EryDex System
5M ago
Quince Therapeutics Appoints Rajiv Patni to Board of Directors
Premium
Company Announcements
Quince Therapeutics Appoints Rajiv Patni to Board of Directors
9M ago
Quince Therapeutics Executive Compensation and Stock Option Update
Premium
Company Announcements
Quince Therapeutics Executive Compensation and Stock Option Update
9M ago
Quince rejects Echo Lake Capital’s $1.60 per share acquisition offer
PremiumThe FlyQuince rejects Echo Lake Capital’s $1.60 per share acquisition offer
2y ago
Quince Therapeutics engages MTS Heath Partners to review strategic alternatives
Premium
The Fly
Quince Therapeutics engages MTS Heath Partners to review strategic alternatives
2y ago
Quince Therapeutics confirms unsolicited acquisition offer from Echo Lake
Premium
The Fly
Quince Therapeutics confirms unsolicited acquisition offer from Echo Lake
2y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100